Description

Geparin-Indar solution for injections 5000 IU/ml. 5 ml. (25000 IU) vial №5

Ingredients:

Each ml contains 5000 IU of Heparin Sodium.

Dosage:

The usual dosage is determined by the healthcare provider based on the patient’s condition. It is administered via injection into a vein or under the skin.

Indications:

Geparin-Indar is indicated for the prevention and treatment of blood clots. It is used in conditions such as deep vein thrombosis, pulmonary embolism, and during certain medical procedures.

Contraindications:

Do not use Geparin-Indar if you have a history of heparin-induced thrombocytopenia or active bleeding. It should be used with caution in patients with a high risk of bleeding.

Directions:

Follow the instructions provided by your healthcare provider for the correct administration of Geparin-Indar. Do not self-administer unless instructed to do so.

Scientific Evidence:

Geparin-Indar has been extensively studied in clinical trials for its efficacy and safety. Research published in the Journal of Thrombosis and Haemostasis demonstrated the effectiveness of Heparin Sodium in preventing venous thromboembolism in surgical patients.

Additional Information:

It is important to monitor the patient’s blood clotting parameters regularly during treatment with Geparin-Indar. Inform your healthcare provider about any unusual bleeding or bruising while using this medication.

The pharmacological action of Heparin involves its interaction with antithrombin III, leading to the inhibition of clotting factors. This mechanism helps prevent the formation of blood clots and is crucial in various medical conditions.